In agreement with this hypothesis, previous studies have described the coexistence of clinical symptoms of CJD and Parkinson’s disease or deposition of both prion and α-synuclein aggregates in brain [3–6,59]. The gene discussed is SNCA; the disease is Parkinson disease.